Cargando…
The risk factors of SARS-CoV-2 antibody level differences in healthcare workers post vaccination in Siloam hospitals: A nationwide multicenter study
BACKGROUND: Several vaccines have been approved against COVID-19, and 5 have been used in Indonesia. Due to the decrease in antibody levels 3 to 6 months after the second dose of CoronaVac, healthcare workers received the third booster of mRNA vaccine (mRNA-1273) to increase the antibody level. This...
Autores principales: | Widysanto, Allen, Prasetya, Ignatius Bima, Meriyanti, Tandry, Sungono, Veli, Setiawan, Diane Lukito, Gunawan, Edy, Adiputra, Bayu, Lorens, Jane Olivia, Santi, Theresia, Pradhana, Cindy Meidy Leony, Yusuf, Irawan, Gunawan, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581641/ https://www.ncbi.nlm.nih.gov/pubmed/38013914 http://dx.doi.org/10.1016/j.imj.2022.10.001 |
Ejemplares similares
-
Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study
por: Lukito, Antonia Anna, et al.
Publicado: (2021) -
Management of necrotizing pneumonia with bronchopleural fistula caused by multidrug‐resistant Acinetobacter baumannii
por: Widysanto, Allen, et al.
Publicado: (2020) -
Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia
por: Prasetya, Ignatius Bima, et al.
Publicado: (2021) -
Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19
por: Widysanto, Allen, et al.
Publicado: (2021) -
The Pool of Siloam
Publicado: (1871)